Last reviewed · How we verify

NCT05583864

Lumbar Fusion With Porous Titanium Versus Non-Porous Titanium-Coated PEEK Interbody Cages - A Randomized Controlled Trial

Active, enrolled NA Last updated 10 February 2026
What this trial tests

NA trial testing CONDUIT Porous Titanium Spinal Cage in Spinal Fusion in 108 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 November 2022
Primary endpoint
31 March 2026
1 June 2027

Quick facts

Lead sponsorFrancis Farhadi
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment108
Start date1 November 2022
Primary completion31 March 2026
Estimated completion1 June 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Francis Farhadi — full company profile →

Who can join

Adults 18 to 80, any sex, with Spinal Fusion or Lumbar Fusion. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The objective of this single site, randomized controlled trial is to assess and compare radiographic and clinical outcomes in patients who are to undergo lumbar interbody fusion procedures (TLIF), supplemented with pedicle screw instrumentation, using one of the following interventions: 1. Porous titanium cages 2. Non-porous titanium-coated poly-ether-ether-ketone (PEEK) cages.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Fusion

Currently open trials in the same condition.

Other Francis Farhadi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05583864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing